Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial

Thomas Zilli, Ciro Franzese, Marta Bottero, Niccolò Giaj-Levra, Robert Förster, Daniel Zwahlen, Nikolaos Koutsouvelis, Aurelie Bertaut, Julie Blanc, Giuseppe Roberto D'agostino, Filippo Alongi, Matthias Guckenberger, Marta Scorsetti, Raymond Miralbell

Research output: Contribution to journalArticle

Abstract

The ONE SHOT trial is the first phase I/II prospective, multicenter, single-arm study assessing the efficacy and safety of a single-dose SBRT for men with localized prostate cancer. Aim of this paper is to present the phase I results of a 19 Gy single fraction urethra-sparing SBRT with real-time electromagnetic tracking.

Original languageEnglish
Pages (from-to)83-86
Number of pages4
JournalRadiotherapy and Oncology
Volume139
DOIs
Publication statusPublished - Oct 2019

    Fingerprint

Cite this

Zilli, T., Franzese, C., Bottero, M., Giaj-Levra, N., Förster, R., Zwahlen, D., Koutsouvelis, N., Bertaut, A., Blanc, J., Roberto D'agostino, G., Alongi, F., Guckenberger, M., Scorsetti, M., & Miralbell, R. (2019). Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial. Radiotherapy and Oncology, 139, 83-86. https://doi.org/10.1016/j.radonc.2019.07.018